Advertisement

Topics

Probi pays $105mm in cash for Nutraceutix

15:40 EDT 18 Oct 2016 | Elsevier Business Intelligence

Probi AG has acquired fellow public nutraceuticals developer Nutraceutix (formerly Scolr Pharma) for $105mm in cash.

Original Article: Probi pays $105mm in cash for Nutraceutix

NEXT ARTICLE

More From BioPortfolio on "Probi pays $105mm in cash for Nutraceutix"

Quick Search
Advertisement